Abstract
AIDS Research and Human RetrovirusesVol. 30, No. S1 Novel Vaccine and Prevention ConceptsVaccine Antigen Design to Maximize anti-HIV CD4+ T-cell Responses: From Mice to Non-human PrimatesEdecio Cunha-Neto, Susan Ribeiro, Daniela Santoro-Rosa, Rafael Almeida, Vinicius Santana, and Jorge KalilEdecio Cunha-NetoUniversity of São Paulo, São Paulo, BrazilSearch for more papers by this author, Susan RibeiroUniversity of São Paulo, São Paulo, BrazilSearch for more papers by this author, Daniela Santoro-RosaFederal University of São Paulo, São Paulo, BrazilSearch for more papers by this author, Rafael AlmeidaUniversity of São Paulo, São Paulo, BrazilSearch for more papers by this author, Vinicius SantanaUniversity of São Paulo, São Paulo, BrazilSearch for more papers by this author, and Jorge KalilUniversity of São Paulo, São Paulo, BrazilSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5533.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Vaccine Antigen Design to Maximize anti-HIV CD4+ T-cell Responses: From Mice to Non-human Primates." AIDS Research and Human Retroviruses, 30(S1), p. A241FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Edecio Cunha-Neto, Susan Ribeiro, Daniela Santoro-Rosa, Rafael Almeida, Vinicius Santana, and Jorge Kalil.Vaccine Antigen Design to Maximize anti-HIV CD4+ T-cell Responses: From Mice to Non-human Primates.AIDS Research and Human Retroviruses.Oct 2014.A241-A241.http://doi.org/10.1089/aid.2014.5533.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
